StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
NASDAQ CALA opened at $0.01 on Tuesday. The stock has a 50 day moving average of $0.02 and a 200-day moving average of $0.02. Calithera Biosciences has a 12 month low of $0.01 and a 12 month high of $0.50.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- With Risk Tolerance, One Size Does Not Fit All
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.PNG?v=20210211152200&h=45&w=95&zc=2){kind=logo}
